Immuneering
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.About IMRX
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.
CEOBenjamin J. Zeskind
CEOBenjamin J. Zeskind
Employees64
Employees64
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2008
Founded2008
Employees64
Employees64
IMRX Key Statistics
Market cap264.71M
Market cap264.71M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume83.96K
Average volume83.96K
High today$10.59
High today$10.59
Low today$9.83
Low today$9.83
Open price$10.15
Open price$10.15
Volume25.83K
Volume25.83K
52 Week high$33.25
52 Week high$33.25
52 Week low$3.74
52 Week low$3.74
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
IMRX Earnings
-$1.61
-$1.07
-$0.54
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Nov 9
ActualExpected Nov 9